<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Colombo, Antonio</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Six-Month DAPT Noninferior to 12-Month Regimen following Stent Implantation</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">15-16</style></pages><abstract><style  face="normal" font="default" size="100%">Results from the Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve Month Dual Antiplatelet Therapy trial [SECURITY; Colombo A et al. J Am Coll Cardiol. 2014. In press] have demonstrated the noninferiority of postprocedural dual antiplatelet therapy for 6 months as compared with 12 months in non-high-risk patients undergoing percutaneous coronary intervention with a second-generation drug eluting stent.</style></abstract><number><style face="normal" font="default" size="100%">30</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>